NB medication (Naltrexone Bupropion combination)

DRUG2 trials

Sponsors

Yale University

Conditions

Binge-Eating DisorderBinge-eating DisorderObesity

Phase 2

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

CompletedNCT03045341

Yale UniversityBinge-eating Disorder, Obesity

Start: 2017-02-27End: 2022-12-16Updated: 2023-03-08

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy

CompletedNCT03047005

Yale UniversityBinge-Eating Disorder, Obesity

Start: 2017-08-28End: 2022-12-16Updated: 2024-02-02

Related Papers

Is there harm in behavioral lifestyle weight management for binge-eating disorder in patients with obesity: Findings from a randomized controlled trial.

2025-05-26